<DOC>
	<DOCNO>NCT00544271</DOCNO>
	<brief_summary>To evaluate immunogenicity , persistence antibody reactogenicity GSK Biologicals ' DTPa ( INFANRIX ) dTpa ( BOOSTRIX ) , administer subject 18-20 month old , compare give booster DTP vaccine 18-20 month . Study double blind two DTP vaccine single blind control arm .</brief_summary>
	<brief_title>Immunogenicity , Antibody Persistence Safety GSK Biologicals ' DTPa ( INFANRIX ) dTpa ( BOOSTRIX ) Vaccines .</brief_title>
	<detailed_description />
	<mesh_term>Diphtheria</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<criteria>Male female child include 18 20 month age time vaccination . Completed primary vaccination course DTPa ( INFANRIX ) vaccine 2 , 4 , 6 month . Written inform consent obtain study entry parent guardian subject . Free obvious health problem establish medical history clinical examination enter study . Use investigational nonregistered drug vaccine study vaccine ( ) within 30 day precede administration study vaccine dose , plan use study period . Evidence previous intercurrent diphtheria , tetanus , pertussis disease , vaccination disease since completion primary course DTPa ( INFANRIX ) vaccine .</criteria>
	<gender>All</gender>
	<minimum_age>18 Months</minimum_age>
	<maximum_age>20 Months</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>BOOSTRIX</keyword>
	<keyword>INFANRIX</keyword>
</DOC>